COVID-19 Message from the Canadian Hemophilia Society – March 31, 2020:
The Canadian Hemophilia Society (CHS) has been following the rapidly evolving COVID-19 crisis and is updating our community regularly via our various communication channels. We recognize that people with bleeding disorders and their caregivers may have questions related to their health care and treatment products.
To read the latest update from the CHS, please visit: bit.ly/CHSmessage-COVID19.
COVID-19 Update from Novo Nordisk:
During the COVID-19 pandemic, our commitment to patients, our employees and the communities where we operate remains unchanged. We will continue to supply our medicines to people living with diabetes and other serious chronic diseases, safeguard the health of our employees, and take actions to support doctors and nurses as they work to defeat COVID-19.
To read the latest update from Novo Nordisk, please visit:
https://www.novonordisk.ca/contact-us/coronavirus-updates.html
COVID-19 and Bleeding Disorders Webinar offered by The World Federation of Hemophilia:
To find out more information about this Webinar that is scheduled on Zoom on April 9th at 10am please visit:
WFH Webinar on Bleeding Disorders and COVID-19
Stay Safe and Healthy!
